The deletion of CXCR6 in tumor-specific CD8+ T cells resulted in reduced retention in tumor tissues and increased CD8+ T-cell recirculation to the spleen, culminating in diminished resident memory response and reduced control of ovarian tumors. The gene discussed is CXCR6; the disease is neoplasm.